Ethical Principles, Data Ethics, and Conflicts of Interest

Quick Answer: Public health ethics rests on three foundational frameworks: the Belmont Report principles (respect for persons, beneficence, and justice), the Common Rule (45 CFR 46) governing human subjects research, and data ethics principles governing equitable collection, maintenance, use, and dissemination of data. Conflicts of interest—financial, personal, and professional—must be identified, disclosed, and managed through recusal, oversight, or divestiture to preserve the integrity of public health decision-making.

The Belmont Report and Ethical Principles

The Belmont Report (1979), produced by the National Commission for the Protection of Human Subjects of Biomedical and Behavioral Research, established three ethical principles that anchor public health research and practice. Respect for persons requires that individuals be treated as autonomous agents capable of self-determination and that persons with diminished autonomy—prisoners, children, cognitively impaired individuals—receive additional protections. Beneficence extends the Hippocratic obligation to do no harm to include maximizing benefits and minimizing harms, not only to individual participants but to populations affected by the research or intervention. Justice addresses the fair distribution of research burdens and benefits, requiring that selection criteria not exploit vulnerable or economically disadvantaged populations.

These principles are not merely aspirational—they are operationalized through informed consent processes, IRB review, risk-benefit analysis, and equitable recruitment strategies. In public health practice, which often involves population-level interventions rather than individual enrollment, the principles require adaptation: community engagement substitutes for individual consent where individual consent is impracticable, and justice considerations extend to the distribution of intervention benefits across entire populations.

The Common Rule and IRB Review

The Federal Policy for the Protection of Human Subjects, known as the Common Rule (45 CFR 46, Subpart A), governs federally funded human subjects research. It defines research as a systematic investigation designed to develop or contribute to generalizable knowledge, and a human subject as a living individual about whom an investigator obtains data through intervention or interaction, or obtains identifiable private information. Institutional Review Boards (IRBs) review proposed research and classify it into three levels:

• Exempt (45 CFR 46.104): Minimal-risk categories including secondary analysis of existing de-identified data, educational research in standard settings, and certain public health surveillance activities; IRB chair or designee confirms exemption status.
• Expedited (45 CFR 46.110): Minimal risk beyond exempt categories, such as collection of blood samples in small volumes, survey or interview procedures with non-vulnerable adults, and prospective collection of biological specimens by noninvasive means.
• Full Board (45 CFR 46.109): Greater than minimal risk; requires convened IRB quorum with diverse expertise.

Informed consent under the Common Rule must include the purpose and duration of the research, procedures to be followed, foreseeable risks, potential benefits, alternatives to participation, confidentiality protections, compensation or treatment for injury, contact information for questions, and a statement that participation is voluntary and may be withdrawn at any time without penalty. The distinction between public health practice and research determines whether IRB review is required: surveillance, outbreak investigation, and program evaluation conducted for internal program improvement may qualify as non-research, while systematic investigation intended to produce generalizable findings constitutes research requiring IRB oversight.

Data Ethics and Equitable Data Principles

Data ethics addresses the full lifecycle of data—collection, maintenance, use, and dissemination—through an equity lens. The FAIR Guiding Principles specify that scientific data should be Findable (persistent identifiers, rich metadata, indexed in searchable resources), Accessible (standardized retrieval protocols, clear access conditions), Interoperable (shared vocabularies and standards), and Reusable (clear licensing, detailed provenance, community standards). Public health datasets must also address algorithmic bias, which arises when training data underrepresent or misrepresent populations, producing tools that perform poorly for the groups most affected by the condition under study.

Equitable data principles require community involvement in defining what data are collected and how they are used, granular disaggregation to surface disparities by race, ethnicity, geography, income, and disability, data sovereignty respecting Indigenous communities' rights to govern their own data, transparency about limitations, and protection against stigmatizing or harmful uses. The collection of social determinants data—including race, ethnicity, sexual orientation, gender identity, and socioeconomic indicators—requires particular care because the same data that illuminate disparities can also stigmatize communities if misused. Public health agencies should establish data governance committees with community representation, define acceptable uses through data sharing agreements, and conduct equity impact assessments before releasing granular data.

Identifying and Managing Conflicts of Interest

A conflict of interest exists when a personal, financial, or professional interest could compromise—or appear to compromise—an individual's independent judgment in the conduct of official duties. Three categories are relevant to public health:

Management strategies include disclosure (the minimum for perceived conflicts), recusal from decisions involving the conflicting interest, divestiture of financial holdings, and management plans with ethics committee oversight. Perceived conflicts—where no actual conflict exists but reasonable observers might question objectivity—are managed with the same rigor as actual conflicts because public trust depends on the appearance as well as the reality of independence. Public health agencies may establish standing disclosure requirements requiring employees and advisory committee members to file annual financial interest statements and update disclosures when new conflicts arise. Advisory committees reviewing vaccine recommendations or research funding decisions frequently encounter financial conflicts with pharmaceutical manufacturers and must balance scientific expertise against undue industry influence.